Home Alzheimer's Genes AD risk factors Bipolar Genes BP risk factors Autism risk factors.Schizophrenia Genes SZ Risk factors Anorexia genes and risk factors .Chronic Fatigue Risk Factors. Multiple sclerosis risk factors . Parkinson's disease genes and risk factors Cystic Fibrosis Herpes simplex database Jobs in genetics and bioinformatics Pathogens Pathways Useful links Videos . Subscribe to Site Updates by Email  Subscribe in a reader . .........................................................

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

These maps, etched out by numerous multiple sclerosis susceptibility gene candidates (see also Genotator) are generated by Kegg pathways from the Kanehisa laboratories with thanks and are subject to their copyright conditions: Genes are enhanced by Click on "show all objects" for genes within figures

Pathway Search Result

hsa04060 Cytokine-cytokine receptor interaction - Homo sapiens (human) (50)



hsa:6346 CCL1, I-309, P500, SCYA1, SISe, TCA3; chemokine (C-C motif) ligand 1; K05514 C-C motif chemokine, other
hsa:6356 CCL11, MGC22554, SCYA11; chemokine (C-C motif) ligand 11; K05509 C-C motif chemokine 7/8/11/12/13
hsa:6357 CCL13, CKb10, MCP-4, MGC17134, NCC-1, NCC1, SCYA13, SCYL1; chemokine (C-C motif) ligand 13; K05509 C-C motif chemokine 7/8/11/12/13
hsa:6358 CCL14, CC-1, CC-3, CKB1, FLJ16015, HCC-1, HCC-1(1-74), HCC-1/HCC-3, HCC-3, MCIF, NCC-2, NCC2, SCYA14, SCYL2, SY14; chemokine (C-C motif) ligand 14; K05514 C-C motif chemokine, other
hsa:6359 CCL15, HCC-2, HMRP-2B, LKN-1, LKN1, MIP-1D, MIP-5, MRP-2B, NCC-3, NCC3, SCYA15, SCYL3, SY15; chemokine (C-C motif) ligand 15; K05511 C-C motif chemokine 15/23
hsa:6347 CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF; chemokine (C-C motif) ligand 2; K14624 C-C motif chemokine 2
hsa:6348 CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3; chemokine (C-C motif) ligand 3; K05408 C-C motif chemokine 3
hsa:6352 CCL5, D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228; chemokine (C-C motif) ligand 5; K12499 C-C motif chemokine 5
hsa:6354 CCL7, FIC, MARC, MCP-3, MCP3, MGC138463, MGC138465, NC28, SCYA6, SCYA7; chemokine (C-C motif) ligand 7; K05509 C-C motif chemokine 7/8/11/12/13
hsa:6355 CCL8, HC14, MCP-2, MCP2, SCYA10, SCYA8; chemokine (C-C motif) ligand 8; K05509 C-C motif chemokine 7/8/11/12/13
hsa:729230 CCR2, CC-CKR-2, CCR2A, CCR2B, CD192, CKR2, CKR2A, CKR2B, CMKBR2, FLJ78302, MCP-1-R, MGC103828, MGC111760, MGC168006; chemokine (C-C motif) receptor 2; K04177 C-C chemokine receptor type 2
hsa:1234 CCR5, CC-CKR-5, CCCKR5, CD195, CKR-5, CKR5, CMKBR5, FLJ78003, IDDM22; chemokine (C-C motif) receptor 5; K04180 C-C chemokine receptor type 5
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:1270 CNTF, HCNTF; ciliary neurotrophic factor; K05420 ciliary neurotrophic factor
hsa:3627 CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1; chemokine (C-X-C motif) ligand 10; K12671 C-X-C motif chemokine 10
hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3451 IFNA17, IFN-alphaI, IFNA, INFA, LEIF2C1; interferon, alpha 17; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3454 IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC; interferon (alpha, beta and omega) receptor 1; K05130 interferon receptor 1
hsa:3455 IFNAR2, IFN-R, IFN-alpha-REC, IFNABR, IFNARB; interferon (alpha, beta and omega) receptor 2; K05131 interferon receptor 2
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3460 IFNGR2, AF-1, IFGR2, IFNGT1; interferon gamma receptor 2 (interferon gamma transducer 1); K05133 interferon gamma receptor 2
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:59067 IL21, IL-21, Za11; interleukin 21; K05434 interleukin 21
hsa:50615 IL21R, MGC10967, NILR; interleukin 21 receptor; K05075 interleukin 21 receptor
hsa:116379 IL22RA2, CRF2-10, CRF2-S1, CRF2X, IL-22BP, IL-22RA2, MGC150509, MGC150510; interleukin 22 receptor, alpha 2; K05139 interleukin 22 receptor alpha 2
hsa:149233 IL23R; interleukin 23 receptor; K05065 interleukin 23 receptor
hsa:55801 IL26, AK155, IL-26; interleukin 26; K05446 interleukin 26
hsa:3559 IL2RA, CD25, IDDM10, IL2R, TCGFR; interleukin 2 receptor, alpha; K05068 interleukin 2 receptor alpha
hsa:3560 IL2RB, CD122, P70-75; interleukin 2 receptor, beta; K05069 interleukin 2 receptor beta
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:3566 IL4R, CD124, IL4RA; interleukin 4 receptor; K05071 interleukin 4 receptor
hsa:3568 IL5RA, CD125, CDw125, HSIL5R3, IL5R, MGC26560; interleukin 5 receptor, alpha; K05067 interleukin 5 receptor alpha
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3574 IL7, IL-7; interleukin 7; K05431 interleukin 7
hsa:3575 IL7R, CD127, CDW127, IL-7R-alpha, IL7RA, ILRA; interleukin 7 receptor; K05072 interleukin 7 receptor
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:4049 LTA, LT, TNFB, TNFSF1; lymphotoxin alpha (TNF superfamily, member 1); K05468 lymphotoxin alpha (TNF superfamily, member 1)
hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A
hsa:7133 TNFRSF1B, CD120b, TBPII, TNF-R-II, TNF-R75, TNFBR, TNFR1B, TNFR2, TNFR80, p75, p75TNFR; tumor necrosis factor receptor superfamily, member 1B; K05141 tumor necrosis factor receptor superfamily member 1B
hsa:8743 TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL; tumor necrosis factor (ligand) superfamily, member 10; K04721 tumor necrosis factor superfamily, member 10

hsa04630 Jak-STAT signaling pathway - Homo sapiens (human) (28)



hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
hsa:1270 CNTF, HCNTF; ciliary neurotrophic factor; K05420 ciliary neurotrophic factor
hsa:3451 IFNA17, IFN-alphaI, IFNA, INFA, LEIF2C1; interferon, alpha 17; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3454 IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC; interferon (alpha, beta and omega) receptor 1; K05130 interferon receptor 1
hsa:3455 IFNAR2, IFN-R, IFN-alpha-REC, IFNABR, IFNARB; interferon (alpha, beta and omega) receptor 2; K05131 interferon receptor 2
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3460 IFNGR2, AF-1, IFGR2, IFNGT1; interferon gamma receptor 2 (interferon gamma transducer 1); K05133 interferon gamma receptor 2
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:59067 IL21, IL-21, Za11; interleukin 21; K05434 interleukin 21
hsa:50615 IL21R, MGC10967, NILR; interleukin 21 receptor; K05075 interleukin 21 receptor
hsa:116379 IL22RA2, CRF2-10, CRF2-S1, CRF2X, IL-22BP, IL-22RA2, MGC150509, MGC150510; interleukin 22 receptor, alpha 2; K05139 interleukin 22 receptor alpha 2
hsa:149233 IL23R; interleukin 23 receptor; K05065 interleukin 23 receptor
hsa:55801 IL26, AK155, IL-26; interleukin 26; K05446 interleukin 26
hsa:3559 IL2RA, CD25, IDDM10, IL2R, TCGFR; interleukin 2 receptor, alpha; K05068 interleukin 2 receptor alpha
hsa:3560 IL2RB, CD122, P70-75; interleukin 2 receptor, beta; K05069 interleukin 2 receptor beta
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:3566 IL4R, CD124, IL4RA; interleukin 4 receptor; K05071 interleukin 4 receptor
hsa:3568 IL5RA, CD125, CDw125, HSIL5R3, IL5R, MGC26560; interleukin 5 receptor, alpha; K05067 interleukin 5 receptor alpha
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3574 IL7, IL-7; interleukin 7; K05431 interleukin 7
hsa:3575 IL7R, CD127, CDW127, IL-7R-alpha, IL7RA, ILRA; interleukin 7 receptor; K05072 interleukin 7 receptor
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:6774 STAT3, APRF, FLJ20882, HIES, MGC16063; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3
hsa:7297 TYK2, JTK1; tyrosine kinase 2 (EC:2.7.10.2); K11219 non-receptor tyrosine kinase [EC:2.7.10.2]

hsa05145 Toxoplasmosis - Homo sapiens (human) (24)



hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:1234 CCR5, CC-CKR-5, CCCKR5, CD195, CKR-5, CKR5, CMKBR5, FLJ78003, IDDM22; chemokine (C-C motif) receptor 5; K04180 C-C chemokine receptor type 5
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:4261 CIITA, C2TA, CIITAIV, MHC2TA, NLRA; class II, major histocompatibility complex, transactivator; K08060 class II, major histocompatibility complex, transactivator
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3460 IFNGR2, AF-1, IFGR2, IFNGT1; interferon gamma receptor 2 (interferon gamma transducer 1); K05133 interferon gamma receptor 2
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:6774 STAT3, APRF, FLJ20882, HIES, MGC16063; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A
hsa:7297 TYK2, JTK1; tyrosine kinase 2 (EC:2.7.10.2); K11219 non-receptor tyrosine kinase [EC:2.7.10.2]

hsa05142 Chagas disease (American trypanosomiasis) - Homo sapiens (human) (24)



hsa:1636 ACE, ACE1, CD143, DCP, DCP1, MGC26566, MVCD3; angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1); K01283 peptidyl-dipeptidase A [EC:3.4.15.1]
hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:6347 CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF; chemokine (C-C motif) ligand 2; K14624 C-C motif chemokine 2
hsa:6348 CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3; chemokine (C-C motif) ligand 3; K05408 C-C motif chemokine 3
hsa:6352 CCL5, D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228; chemokine (C-C motif) ligand 5; K12499 C-C motif chemokine 5
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3460 IFNGR2, AF-1, IFGR2, IFNGT1; interferon gamma receptor 2 (interferon gamma transducer 1); K05133 interferon gamma receptor 2
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5054 SERPINE1, PAI, PAI-1, PAI1, PLANH1; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1; K03982 plasminogen activator inhibitor-1
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A

hsa04062 Chemokine signaling pathway - Homo sapiens (human) (22)



hsa:6346 CCL1, I-309, P500, SCYA1, SISe, TCA3; chemokine (C-C motif) ligand 1; K05514 C-C motif chemokine, other
hsa:6356 CCL11, MGC22554, SCYA11; chemokine (C-C motif) ligand 11; K05509 C-C motif chemokine 7/8/11/12/13
hsa:6357 CCL13, CKb10, MCP-4, MGC17134, NCC-1, NCC1, SCYA13, SCYL1; chemokine (C-C motif) ligand 13; K05509 C-C motif chemokine 7/8/11/12/13
hsa:6358 CCL14, CC-1, CC-3, CKB1, FLJ16015, HCC-1, HCC-1(1-74), HCC-1/HCC-3, HCC-3, MCIF, NCC-2, NCC2, SCYA14, SCYL2, SY14; chemokine (C-C motif) ligand 14; K05514 C-C motif chemokine, other
hsa:6359 CCL15, HCC-2, HMRP-2B, LKN-1, LKN1, MIP-1D, MIP-5, MRP-2B, NCC-3, NCC3, SCYA15, SCYL3, SY15; chemokine (C-C motif) ligand 15; K05511 C-C motif chemokine 15/23
hsa:6347 CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF; chemokine (C-C motif) ligand 2; K14624 C-C motif chemokine 2
hsa:6348 CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3; chemokine (C-C motif) ligand 3; K05408 C-C motif chemokine 3
hsa:6352 CCL5, D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228; chemokine (C-C motif) ligand 5; K12499 C-C motif chemokine 5
hsa:6354 CCL7, FIC, MARC, MCP-3, MCP3, MGC138463, MGC138465, NC28, SCYA6, SCYA7; chemokine (C-C motif) ligand 7; K05509 C-C motif chemokine 7/8/11/12/13
hsa:6355 CCL8, HC14, MCP-2, MCP2, SCYA10, SCYA8; chemokine (C-C motif) ligand 8; K05509 C-C motif chemokine 7/8/11/12/13
hsa:729230 CCR2, CC-CKR-2, CCR2A, CCR2B, CD192, CKR2, CKR2A, CKR2B, CMKBR2, FLJ78302, MCP-1-R, MGC103828, MGC111760, MGC168006; chemokine (C-C motif) receptor 2; K04177 C-C chemokine receptor type 2
hsa:1234 CCR5, CC-CKR-5, CCCKR5, CD195, CKR-5, CKR5, CMKBR5, FLJ78003, IDDM22; chemokine (C-C motif) receptor 5; K04180 C-C chemokine receptor type 5
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:3627 CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1; chemokine (C-X-C motif) ligand 10; K12671 C-X-C motif chemokine 10
hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:6774 STAT3, APRF, FLJ20882, HIES, MGC16063; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene

hsa04650 Natural killer cell mediated cytotoxicity - Homo sapiens (human) (22)



hsa:962 CD48, BCM1, BLAST, BLAST1, MEM-102, SLAMF2, hCD48, mCD48; CD48 molecule; K06479 CD48 antigen
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1
hsa:3451 IFNA17, IFN-alphaI, IFNA, INFA, LEIF2C1; interferon, alpha 17; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3454 IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC; interferon (alpha, beta and omega) receptor 1; K05130 interferon receptor 1
hsa:3455 IFNAR2, IFN-R, IFN-alpha-REC, IFNABR, IFNARB; interferon (alpha, beta and omega) receptor 2; K05131 interferon receptor 2
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3460 IFNGR2, AF-1, IFGR2, IFNGT1; interferon gamma receptor 2 (interferon gamma transducer 1); K05133 interferon gamma receptor 2
hsa:3803 KIR2DL2, CD158B1, CD158b, NKAT6, p58.2; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2; K07981 killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail
hsa:3806 KIR2DS1, CD158H, CD158a, p50.1; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1; K07982 killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail
hsa:3811 KIR3DL1, CD158E1, KIR, MGC119726, MGC119728, MGC126589, MGC126591, NKAT3, NKB1, NKB1B; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1; K07980 killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail
hsa:4277 MICB, PERB11.2; MHC class I polypeptide-related sequence B; K07985 MHC class I-related protein
hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:8743 TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL; tumor necrosis factor (ligand) superfamily, member 10; K04721 tumor necrosis factor superfamily, member 10
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene

hsa05200 Pathways in cancer - Homo sapiens (human) (21)



hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1630 DCC, CRC18, CRCR1, IGDCC1; deleted in colorectal carcinoma; K06765 deleted in colorectal carcinoma
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:2950 GSTP1, DFN7, FAEES3, GST3, GSTP, PI; glutathione S-transferase pi 1 (EC:2.5.1.18); K00799 glutathione S-transferase [EC:2.5.1.18]
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
hsa:4313 MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1; matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24); K01398 matrix metalloproteinase-2 (gelatinase A) [EC:3.4.24.24]
hsa:4318 MMP9, CLG4B, GELB, MANDP2, MMP-9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35); K01403 matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35]
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:5468 PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma; peroxisome proliferator-activated receptor gamma; K08530 peroxisome proliferator-activated receptor gamma
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:6774 STAT3, APRF, FLJ20882, HIES, MGC16063; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1

hsa04620 Toll-like receptor signaling pathway - Homo sapiens (human) (20)



hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:6348 CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3; chemokine (C-C motif) ligand 3; K05408 C-C motif chemokine 3
hsa:6352 CCL5, D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228; chemokine (C-C motif) ligand 5; K12499 C-C motif chemokine 5
hsa:929 CD14; CD14 molecule; K04391 CD14 antigen
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:3627 CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1; chemokine (C-X-C motif) ligand 10; K12671 C-X-C motif chemokine 10
hsa:3451 IFNA17, IFN-alphaI, IFNA, INFA, LEIF2C1; interferon, alpha 17; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3454 IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC; interferon (alpha, beta and omega) receptor 1; K05130 interferon receptor 1
hsa:3455 IFNAR2, IFN-R, IFN-alpha-REC, IFNABR, IFNARB; interferon (alpha, beta and omega) receptor 2; K05131 interferon receptor 2
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:3663 IRF5, SLEB10; interferon regulatory factor 5; K09446 interferon regulatory factor 5
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04514 Cell adhesion molecules (CAMs) - Homo sapiens (human) (19)



hsa:10666 CD226, DNAM-1, DNAM1, PTA1, TLiSA1; CD226 molecule; K06567 CD226 antigen
hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:920 CD4, CD4mut; CD4 molecule; K06454 CD4 antigen
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:965 CD58, FLJ23181, FLJ43722, LFA-3, LFA3; CD58 molecule; K06492 CD58 antigen
hsa:923 CD6, FLJ44171, TP120; CD6 molecule; K06456 CD6 antigen
hsa:26047 CNTNAP2, AUTS15, CASPR2, CDFE, DKFZp781D1846, NRXN4, PTHSL1; contactin associated protein-like 2; K07380 contactin associated protein-like 2
hsa:1493 CTLA4, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, ICOS, IDDM12; cytotoxic T-lymphocyte-associated protein 4; K06538 cytotoxic T-lymphocyte-associated protein 4
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1
hsa:29851 ICOS, AILIM, CD278, CVID1, MGC39850; inducible T-cell co-stimulator; K06713 inducible T-cell co-stimulator
hsa:5133 PDCD1, CD279, PD1, SLEB2, hPD-1, hPD-l; programmed cell death 1; K06744 programmed cell death protein 1
hsa:5788 PTPRC, B220, CD45, CD45R, GP180, LCA, LY5, T200; protein tyrosine phosphatase, receptor type, C (EC:3.1.3.48); K06478 protein tyrosine phosphatase, receptor type, C [EC:3.1.3.48]
hsa:6401 SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2; selectin E; K06494 selectin, endothelial cell
hsa:6404 SELPLG, CD162, CLA, PSGL-1, PSGL1; selectin P ligand; K06544 selectin P ligand

hsa05140 Leishmaniasis - Homo sapiens (human) (18)



hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a
hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3460 IFNGR2, AF-1, IFGR2, IFNGT1; interferon gamma receptor 2 (interferon gamma transducer 1); K05133 interferon gamma receptor 2
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05330 Allograft rejection - Homo sapiens (human) (17)



hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04380 Osteoclast differentiation - Homo sapiens (human) (17)



hsa:54 ACP5, MGC117378, TRAP; acid phosphatase 5, tartrate resistant (EC:3.1.3.2); K14379 tartrate-resistant acid phosphatase type 5 [EC:3.1.3.2]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a
hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:3454 IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC; interferon (alpha, beta and omega) receptor 1; K05130 interferon receptor 1
hsa:3455 IFNAR2, IFN-R, IFN-alpha-REC, IFNABR, IFNARB; interferon (alpha, beta and omega) receptor 2; K05131 interferon receptor 2
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3460 IFNGR2, AF-1, IFGR2, IFNGT1; interferon gamma receptor 2 (interferon gamma transducer 1); K05133 interferon gamma receptor 2
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:11026 LILRA3, CD85E, HM31, HM43, ILT6, LIR-4, LIR4, e3; leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3; K06512 leukocyte immunoglobulin-like receptor
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:5468 PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma; peroxisome proliferator-activated receptor gamma; K08530 peroxisome proliferator-activated receptor gamma
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A
hsa:7297 TYK2, JTK1; tyrosine kinase 2 (EC:2.7.10.2); K11219 non-receptor tyrosine kinase [EC:2.7.10.2]

hsa05320 Autoimmune thyroid disease - Homo sapiens (human) (16)



hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:1493 CTLA4, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, ICOS, IDDM12; cytotoxic T-lymphocyte-associated protein 4; K06538 cytotoxic T-lymphocyte-associated protein 4
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3451 IFNA17, IFN-alphaI, IFNA, INFA, LEIF2C1; interferon, alpha 17; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1

hsa04940 Type I diabetes mellitus - Homo sapiens (human) (16)



hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:4049 LTA, LT, TNFB, TNFSF1; lymphotoxin alpha (TNF superfamily, member 1); K05468 lymphotoxin alpha (TNF superfamily, member 1)
hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa01100 Metabolic pathways - Homo sapiens (human) (16)

hsa:10317 B3GALT5, B3GalT-V, B3GalTx, B3T5, GLCT5, beta3Gal-T5; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5; K03877 beta-1,3-galactosyltransferase 5 [EC:2.4.1.-]
hsa:56913 C1GALT1, C1GALT, T-synthase; core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 (EC:2.4.1.122); K00731 glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase [EC:2.4.1.122]
hsa:1589 CYP21A2, CA21H, CAH1, CPS1, CYP21, CYP21B, MGC150536, MGC150537, P450c21B; cytochrome P450, family 21, subfamily A, polypeptide 2 (EC:1.14.99.10); K00513 cytochrome P450, family 21, subfamily A (steroid 21-monooxygenase) [EC:1.14.99.10]
hsa:1594 CYP27B1, CP2B, CYP1, CYP1alpha, CYP27B, P450c1, PDDR, VDD1, VDDR, VDDRI, VDR; cytochrome P450, family 27, subfamily B, polypeptide 1 (EC:1.14.13.13); K07438 cytochrome P450, family 27, subfamily B (25-hydroxyvitamin D3 1alpha-hydroxylase) [EC:1.14.13.13]
hsa:2530 FUT8, MGC26465; fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (EC:2.4.1.68); K00717 glycoprotein 6-alpha-L-fucosyltransferase [EC:2.4.1.68]
hsa:9563 H6PD, DKFZp686A01246, G6PDH, GDH, MGC87643; hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) (EC:1.1.1.47 3.1.1.31); K13937 hexose-6-phosphate dehydrogenase [EC:1.1.1.47 3.1.1.31]
hsa:3632 INPP5A, 5PTASE, DKFZp434A1721, MGC116947, MGC116949; inositol polyphosphate-5-phosphatase, 40kDa (EC:3.1.3.56); K01106 inositol-1,4,5-trisphosphate 5-phosphatase [EC:3.1.3.56]
hsa:4524 MTHFR; methylenetetrahydrofolate reductase (NAD(P)H) (EC:1.5.1.20); K00297 methylenetetrahydrofolate reductase (NADPH) [EC:1.5.1.20]
hsa:4725 NDUFS5, CI-15k, CI15K; NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase); K03938 NADH dehydrogenase (ubiquinone) Fe-S protein 5 [EC:1.6.5.3 1.6.99.3]
hsa:374291 NDUFS7, CI-20, CI-20KD, FLJ45860, FLJ46880, MGC120002, MY017, PSST; NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3); K03940 NADH dehydrogenase (ubiquinone) Fe-S protein 7 [EC:1.6.5.3 1.6.99.3]
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:7941 PLA2G7, LDL-PLA2, LP-PLA2, PAFAH; phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (EC:3.1.1.47); K01062 1-alkyl-2-acetylglycerophosphocholine esterase [EC:3.1.1.47]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5409 PNMT, MGC34570, PENT, PNMTase; phenylethanolamine N-methyltransferase (EC:2.1.1.28); K00553 phenylethanolamine N-methyltransferase [EC:2.1.1.28]
hsa:5444 PON1, ESA, MVCD5, PON; paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81); K01045 arylesterase / paraoxonase [EC:3.1.1.2 3.1.8.1]
hsa:55312 RFK, FLJ11149, RIFK; riboflavin kinase (EC:2.7.1.26); K00861 riboflavin kinase [EC:2.7.1.26]

hsa05332 Graft-versus-host disease - Homo sapiens (human) (16)



hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3803 KIR2DL2, CD158B1, CD158b, NKAT6, p58.2; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2; K07981 killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail
hsa:3811 KIR3DL1, CD158E1, KIR, MGC119726, MGC119728, MGC126589, MGC126591, NKAT3, NKB1, NKB1B; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1; K07980 killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail
hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04660 T cell receptor signaling pathway - Homo sapiens (human) (16)



hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:920 CD4, CD4mut; CD4 molecule; K06454 CD4 antigen
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1493 CTLA4, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, ICOS, IDDM12; cytotoxic T-lymphocyte-associated protein 4; K06538 cytotoxic T-lymphocyte-associated protein 4
hsa:29851 ICOS, AILIM, CD278, CVID1, MGC39850; inducible T-cell co-stimulator; K06713 inducible T-cell co-stimulator
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:5133 PDCD1, CD279, PD1, SLEB2, hPD-1, hPD-l; programmed cell death 1; K06744 programmed cell death protein 1
hsa:5788 PTPRC, B220, CD45, CD45R, GP180, LCA, LY5, T200; protein tyrosine phosphatase, receptor type, C (EC:3.1.3.48); K06478 protein tyrosine phosphatase, receptor type, C [EC:3.1.3.48]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene

hsa05160 Hepatitis C - Homo sapiens (human) (16)



hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:5610 EIF2AK2, EIF2AK1, MGC126524, PKR, PRKR; eukaryotic translation initiation factor 2-alpha kinase 2 (EC:2.7.11.1); K08860 eukaryotic translation initiation factor 2-alpha kinase [EC:2.7.11.1]
hsa:3434 IFIT1, C56, G10P1, GARG-16, IFI-56, IFI-56K, IFI56, IFIT-1, IFNAI1, ISG56, RNM561; interferon-induced protein with tetratricopeptide repeats 1; K14217 interferon-induced protein with tetratricopeptide repeats 1
hsa:3451 IFNA17, IFN-alphaI, IFNA, INFA, LEIF2C1; interferon, alpha 17; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3454 IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC; interferon (alpha, beta and omega) receptor 1; K05130 interferon receptor 1
hsa:3455 IFNAR2, IFN-R, IFN-alpha-REC, IFNABR, IFNARB; interferon (alpha, beta and omega) receptor 2; K05131 interferon receptor 2
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:3659 IRF1, IRF-1, MAR; interferon regulatory factor 1; K09444 interferon regulatory factor 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4938 OAS1, IFI-4, OIAS, OIASI; 2',5'-oligoadenylate synthetase 1, 40/46kDa (EC:2.7.7.-); K14216 2'-5'-oligoadenylate synthetase
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:6774 STAT3, APRF, FLJ20882, HIES, MGC16063; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A
hsa:7297 TYK2, JTK1; tyrosine kinase 2 (EC:2.7.10.2); K11219 non-receptor tyrosine kinase [EC:2.7.10.2]

hsa04612 Antigen processing and presentation - Homo sapiens (human) (15)



hsa:920 CD4, CD4mut; CD4 molecule; K06454 CD4 antigen
hsa:4261 CIITA, C2TA, CIITAIV, MHC2TA, NLRA; class II, major histocompatibility complex, transactivator; K08060 class II, major histocompatibility complex, transactivator
hsa:1520 CTSS, FLJ50259, MGC3886; cathepsin S (EC:3.4.22.27); K01368 cathepsin S [EC:3.4.22.27]
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:10437 IFI30, GILT, IFI-30, IP30, MGC32056; interferon, gamma-inducible protein 30; K08059 interferon, gamma-inducible protein 30
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3803 KIR2DL2, CD158B1, CD158b, NKAT6, p58.2; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2; K07981 killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail
hsa:3806 KIR2DS1, CD158H, CD158a, p50.1; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1; K07982 killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail
hsa:3811 KIR3DL1, CD158E1, KIR, MGC119726, MGC119728, MGC126589, MGC126591, NKAT3, NKB1, NKB1B; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1; K07980 killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail
hsa:6891 TAP2, ABC18, ABCB3, APT2, D6S217E, PSF2, RING11; transporter 2, ATP-binding cassette, sub-family B (MDR/TAP); K05654 ATP-binding cassette, subfamily B (MDR/TAP), member 3
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04640 Hematopoietic cell lineage - Homo sapiens (human) (14)



hsa:929 CD14; CD14 molecule; K04391 CD14 antigen
hsa:100133941 CD24, CD24A, FLJ22950, FLJ43543, MGC75043; CD24 molecule; K06469 CD24 antigen
hsa:920 CD4, CD4mut; CD4 molecule; K06454 CD4 antigen
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3559 IL2RA, CD25, IDDM10, IL2R, TCGFR; interleukin 2 receptor, alpha; K05068 interleukin 2 receptor alpha
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:3566 IL4R, CD124, IL4RA; interleukin 4 receptor; K05071 interleukin 4 receptor
hsa:3568 IL5RA, CD125, CDw125, HSIL5R3, IL5R, MGC26560; interleukin 5 receptor, alpha; K05067 interleukin 5 receptor alpha
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3574 IL7, IL-7; interleukin 7; K05431 interleukin 7
hsa:3575 IL7R, CD127, CDW127, IL-7R-alpha, IL7RA, ILRA; interleukin 7 receptor; K05072 interleukin 7 receptor
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05144 Malaria - Homo sapiens (human) (14)



hsa:6347 CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF; chemokine (C-C motif) ligand 2; K14624 C-C motif chemokine 2
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:3820 KLRB1, CD161, CLEC5B, MGC138614, NKR, NKR-P1, NKR-P1A, NKRP1A, hNKR-P1A; killer cell lectin-like receptor subfamily B, member 1; K06543 killer cell lectin-like receptor subfamily B
hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
hsa:6401 SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2; selectin E; K06494 selectin, endothelial cell
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05322 Systemic lupus erythematosus - Homo sapiens (human) (14)



hsa:720 C4A, C4, C4A2, C4A3, C4A4, C4A6, C4S, CO4, CPAMD2, MGC164979, RG; complement component 4A (Rodgers blood group); K03989 complement component 4
hsa:727 C5, CPAMD4, FLJ17816, FLJ17822, MGC142298; complement component 5; K03994 complement component 5
hsa:730 C7; complement component 7; K03996 complement component 7
hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a
hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05416 Viral myocarditis - Homo sapiens (human) (14)



hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:857 CAV1, BSCL3, CGL3, MSTP085, VIP21; caveolin 1, caveolae protein, 22kDa; K06278 caveolin 1
hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:1756 DMD, BMD, CMD3B, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272; dystrophin; K10366 dystrophin
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1
hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1
hsa:6444 SGCD, 35DAG, CMD1L, DAGD, MGC22567, SG-delta, SGCDP, SGD; sarcoglycan, delta (35kDa dystrophin-associated glycoprotein); K12563 delta-sarcoglycan

hsa04144 Endocytosis - Homo sapiens (human) (13)



hsa:116986 AGAP2, CENTG1, FLJ16430, GGAP2, KIAA0167, PIKE; ArfGAP with GTPase domain, ankyrin repeat and PH domain 2; K12491 Arf-GAP, GTPase, ANK repeat and PH domain-containing protein 1/2/3
hsa:50807 ASAP1, AMAP1, CENTB4, DDEF1, KIAA1249, PAG2, PAP, ZG14P; ArfGAP with SH3 domain, ankyrin repeat and PH domain 1; K12488 Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein
hsa:857 CAV1, BSCL3, CGL3, MSTP085, VIP21; caveolin 1, caveolae protein, 22kDa; K06278 caveolin 1
hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
hsa:1234 CCR5, CC-CKR-5, CCCKR5, CD195, CKR-5, CKR5, CMKBR5, FLJ78003, IDDM22; chemokine (C-C motif) receptor 5; K04180 C-C chemokine receptor type 5
hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4
hsa:2065 ERBB3, ErbB-3, HER3, LCCS2, MDA-BF-1, MGC88033, c-erbB-3, c-erbB3, erbB3-S, p180-ErbB3, p45-sErbB3, p85-sErbB3; v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (EC:2.7.10.1); K05084 receptor tyrosine-protein kinase erbB-3 [EC:2.7.10.1]
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3559 IL2RA, CD25, IDDM10, IL2R, TCGFR; interleukin 2 receptor, alpha; K05068 interleukin 2 receptor alpha
hsa:3560 IL2RB, CD122, P70-75; interleukin 2 receptor, beta; K05069 interleukin 2 receptor beta
hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
hsa:6456 SH3GL2, CNSA2, EEN-B1, FLJ20276, FLJ25015, SH3D2A, SH3P4; SH3-domain GRB2-like 2; K11247 endophilin-A
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1

hsa05143 African trypanosomiasis - Homo sapiens (human) (13)



hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:6401 SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2; selectin E; K06494 selectin, endothelial cell
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04672 Intestinal immune network for IgA production - Homo sapiens (human) (13)




hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:29851 ICOS, AILIM, CD278, CVID1, MGC39850; inducible T-cell co-stimulator; K06713 inducible T-cell co-stimulator
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1

hsa05146 Amoebiasis - Homo sapiens (human) (13)



hsa:929 CD14; CD14 molecule; K04391 CD14 antigen
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04210 Apoptosis - Homo sapiens (human) (12)



hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4803 NGF, Beta-NGF, HSAN5, MGC161426, MGC161428, NGFB; nerve growth factor (beta polypeptide); K02582 nerve growth factor, beta
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A
hsa:8743 TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL; tumor necrosis factor (ligand) superfamily, member 10; K04721 tumor necrosis factor superfamily, member 10

hsa04010 MAPK signaling pathway - Homo sapiens (human) (12)



hsa:627 BDNF, MGC34632; brain-derived neurotrophic factor; K04355 brain-derived neurotrophic factor
hsa:27091 CACNG5, MGC126656, MGC126682; calcium channel, voltage-dependent, gamma subunit 5; K04870 voltage-dependent calcium channel gamma-5
hsa:929 CD14; CD14 molecule; K04391 CD14 antigen
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:4803 NGF, Beta-NGF, HSAN5, MGC161426, MGC161428, NGFB; nerve growth factor (beta polypeptide); K02582 nerve growth factor, beta
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A

hsa05150 Staphylococcus aureus infection - Homo sapiens (human) (12)



hsa:720 C4A, C4, C4A2, C4A3, C4A4, C4A6, C4S, CO4, CPAMD2, MGC164979, RG; complement component 4A (Rodgers blood group); K03989 complement component 4
hsa:727 C5, CPAMD4, FLJ17816, FLJ17822, MGC142298; complement component 5; K03994 complement component 5
hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a
hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:5724 PTAFR, PAFR; platelet-activating factor receptor; K04279 platelet-activating factor receptor
hsa:6404 SELPLG, CD162, CLA, PSGL-1, PSGL1; selectin P ligand; K06544 selectin P ligand

hsa05010 Alzheimer's disease - Homo sapiens (human) (11)



hsa:348 APOE, AD2, LDLCQ5, LPG, MGC1571; apolipoprotein E; K04524 apolipoprotein E
hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:4725 NDUFS5, CI-15k, CI15K; NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase); K03938 NADH dehydrogenase (ubiquinone) Fe-S protein 5 [EC:1.6.5.3 1.6.99.3]
hsa:374291 NDUFS7, CI-20, CI-20KD, FLJ45860, FLJ46880, MGC120002, MY017, PSST; NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3); K03940 NADH dehydrogenase (ubiquinone) Fe-S protein 7 [EC:1.6.5.3 1.6.99.3]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:6263 RYR3; ryanodine receptor 3; K04963 ryanodine receptor 3
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A

hsa04622 RIG-I-like receptor signaling pathway - Homo sapiens (human) (11)



hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:3627 CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1; chemokine (C-X-C motif) ligand 10; K12671 C-X-C motif chemokine 10
hsa:64135 IFIH1, Hlcd, IDDM19, MDA-5, MDA5, MGC133047; interferon induced with helicase C domain 1 (EC:3.6.4.13); K12647 interferon-induced helicase C domain-containing protein 1 [EC:3.6.4.13]
hsa:3451 IFNA17, IFN-alphaI, IFNA, INFA, LEIF2C1; interferon, alpha 17; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04145 Phagosome - Homo sapiens (human) (11)



hsa:929 CD14; CD14 molecule; K04391 CD14 antigen
hsa:1520 CTSS, FLJ50259, MGC3886; cathepsin S (EC:3.4.22.27); K01368 cathepsin S [EC:3.4.22.27]
hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a
hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:4353 MPO; myeloperoxidase (EC:1.11.1.7); K10789 myeloperoxidase [EC:1.11.1.7]
hsa:6891 TAP2, ABC18, ABCB3, APT2, D6S217E, PSF2, RING11; transporter 2, ATP-binding cassette, sub-family B (MDR/TAP); K05654 ATP-binding cassette, subfamily B (MDR/TAP), member 3

hsa04621 NOD-like receptor signaling pathway - Homo sapiens (human) (10)



hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:6347 CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF; chemokine (C-C motif) ligand 2; K14624 C-C motif chemokine 2
hsa:6352 CCL5, D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228; chemokine (C-C motif) ligand 5; K12499 C-C motif chemokine 5
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:4210 MEFV, FMF, MEF, MGC126560, MGC126586, TRIM20; Mediterranean fever; K12803 pyrin
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05310 Asthma - Homo sapiens (human) (9)



hsa:6356 CCL11, MGC22554, SCYA11; chemokine (C-C motif) ligand 11; K05509 C-C motif chemokine 7/8/11/12/13
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04080 Neuroactive ligand-receptor interaction - Homo sapiens (human) (8)



hsa:1268 CNR1, CANN6, CB-R, CB1, CB1A, CB1K5, CB1R, CNR; cannabinoid receptor 1 (brain); K04277 cannabinoid receptor 1
hsa:1394 CRHR1, CRF-R, CRF1, CRFR1, CRH-R1h, CRHR, CRHR1L, CRHR1f; corticotropin releasing hormone receptor 1; K04578 corticotropin releasing hormone receptor 1
hsa:2556 GABRA3, MGC33793; gamma-aminobutyric acid (GABA) A receptor, alpha 3; K05177 gamma-aminobutyric acid (GABA) A receptor alpha-3
hsa:2696 GIPR, MGC126722, PGQTL2; gastric inhibitory polypeptide receptor; K04580 gastric inhibitory polypeptide receptor
hsa:4157 MC1R, CMM5, MGC14337, MSH-R, SHEP2; melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor); K04199 melanocortin 1 receptor
hsa:2908 NR3C1, GCCR, GCR, GR, GRL; nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor); K05771 glucocorticoid receptor
hsa:5724 PTAFR, PAFR; platelet-activating factor receptor; K04279 platelet-activating factor receptor
hsa:5734 PTGER4, EP4, EP4R, MGC126583; prostaglandin E receptor 4 (subtype EP4); K04261 prostaglandin E receptor 4

hsa04623 Cytosolic DNA-sensing pathway - Homo sapiens (human) (8)



hsa:6352 CCL5, D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228; chemokine (C-C motif) ligand 5; K12499 C-C motif chemokine 5
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:3627 CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1; chemokine (C-X-C motif) ligand 10; K12671 C-X-C motif chemokine 10
hsa:3451 IFNA17, IFN-alphaI, IFNA, INFA, LEIF2C1; interferon, alpha 17; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha

hsa04670 Leukocyte transendothelial migration - Homo sapiens (human) (7)



hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4
hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1
hsa:4313 MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1; matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24); K01398 matrix metalloproteinase-2 (gelatinase A) [EC:3.4.24.24]
hsa:4318 MMP9, CLG4B, GELB, MANDP2, MMP-9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35); K01403 matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene

hsa05340 Primary immunodeficiency - Homo sapiens (human) (7)



hsa:920 CD4, CD4mut; CD4 molecule; K06454 CD4 antigen
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:4261 CIITA, C2TA, CIITAIV, MHC2TA, NLRA; class II, major histocompatibility complex, transactivator; K08060 class II, major histocompatibility complex, transactivator
hsa:29851 ICOS, AILIM, CD278, CVID1, MGC39850; inducible T-cell co-stimulator; K06713 inducible T-cell co-stimulator
hsa:3575 IL7R, CD127, CDW127, IL-7R-alpha, IL7RA, ILRA; interleukin 7 receptor; K05072 interleukin 7 receptor
hsa:5788 PTPRC, B220, CD45, CD45R, GP180, LCA, LY5, T200; protein tyrosine phosphatase, receptor type, C (EC:3.1.3.48); K06478 protein tyrosine phosphatase, receptor type, C [EC:3.1.3.48]
hsa:6891 TAP2, ABC18, ABCB3, APT2, D6S217E, PSF2, RING11; transporter 2, ATP-binding cassette, sub-family B (MDR/TAP); K05654 ATP-binding cassette, subfamily B (MDR/TAP), member 3

hsa05016 Huntington's disease - Homo sapiens (human) (7)



hsa:627 BDNF, MGC34632; brain-derived neurotrophic factor; K04355 brain-derived neurotrophic factor
hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:4725 NDUFS5, CI-15k, CI15K; NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase); K03938 NADH dehydrogenase (ubiquinone) Fe-S protein 5 [EC:1.6.5.3 1.6.99.3]
hsa:374291 NDUFS7, CI-20, CI-20KD, FLJ45860, FLJ46880, MGC120002, MY017, PSST; NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3); K03940 NADH dehydrogenase (ubiquinone) Fe-S protein 7 [EC:1.6.5.3 1.6.99.3]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5468 PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma; peroxisome proliferator-activated receptor gamma; K08530 peroxisome proliferator-activated receptor gamma

hsa04510 Focal adhesion - Homo sapiens (human) (7)



hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:857 CAV1, BSCL3, CGL3, MSTP085, VIP21; caveolin 1, caveolae protein, 22kDa; K06278 caveolin 1
hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5649 RELN, PRO1598, RL; reelin; K06249 reelin [EC:3.4.21.-]
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene

hsa05410 Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human) (7)



hsa:1636 ACE, ACE1, CD143, DCP, DCP1, MGC26566, MVCD3; angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1); K01283 peptidyl-dipeptidase A [EC:3.4.15.1]
hsa:27091 CACNG5, MGC126656, MGC126682; calcium channel, voltage-dependent, gamma subunit 5; K04870 voltage-dependent calcium channel gamma-5
hsa:1756 DMD, BMD, CMD3B, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272; dystrophin; K10366 dystrophin
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:6444 SGCD, 35DAG, CMD1L, DAGD, MGC22567, SG-delta, SGCDP, SGD; sarcoglycan, delta (35kDa dystrophin-associated glycoprotein); K12563 delta-sarcoglycan
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05014 Amyotrophic lateral sclerosis (ALS) - Homo sapiens (human) (6)



hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A
hsa:7133 TNFRSF1B, CD120b, TBPII, TNF-R-II, TNF-R75, TNFBR, TNFR1B, TNFR2, TNFR80, p75, p75TNFR; tumor necrosis factor receptor superfamily, member 1B; K05141 tumor necrosis factor receptor superfamily member 1B
hsa:10452 TOMM40, C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40; translocase of outer mitochondrial membrane 40 homolog (yeast); K11518 mitochondrial import receptor subunit TOM40

hsa04666 Fc gamma R-mediated phagocytosis - Homo sapiens (human) (6)



hsa:50807 ASAP1, AMAP1, CENTB4, DDEF1, KIAA1249, PAG2, PAP, ZG14P; ArfGAP with SH3 domain, ankyrin repeat and PH domain 1; K12488 Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein
hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5788 PTPRC, B220, CD45, CD45R, GP180, LCA, LY5, T200; protein tyrosine phosphatase, receptor type, C (EC:3.1.3.48); K06478 protein tyrosine phosphatase, receptor type, C [EC:3.1.3.48]
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene

hsa04920 Adipocytokine signaling pathway - Homo sapiens (human) (6)



hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:6774 STAT3, APRF, FLJ20882, HIES, MGC16063; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A
hsa:7133 TNFRSF1B, CD120b, TBPII, TNF-R-II, TNF-R75, TNFBR, TNFR1B, TNFR2, TNFR80, p75, p75TNFR; tumor necrosis factor receptor superfamily, member 1B; K05141 tumor necrosis factor receptor superfamily member 1B

hsa04020 Calcium signaling pathway - Homo sapiens (human) (6)



hsa:2065 ERBB3, ErbB-3, HER3, LCCS2, MDA-BF-1, MGC88033, c-erbB-3, c-erbB3, erbB3-S, p180-ErbB3, p45-sErbB3, p85-sErbB3; v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (EC:2.7.10.1); K05084 receptor tyrosine-protein kinase erbB-3 [EC:2.7.10.1]
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5724 PTAFR, PAFR; platelet-activating factor receptor; K04279 platelet-activating factor receptor
hsa:6263 RYR3; ryanodine receptor 3; K04963 ryanodine receptor 3

hsa04722 Neurotrophin signaling pathway - Homo sapiens (human) (6)



hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:627 BDNF, MGC34632; brain-derived neurotrophic factor; K04355 brain-derived neurotrophic factor
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4803 NGF, Beta-NGF, HSAN5, MGC161426, MGC161428, NGFB; nerve growth factor (beta polypeptide); K02582 nerve growth factor, beta
hsa:10019 SH2B3, IDDM20, LNK; SH2B adaptor protein 3; K12459 SH2B adaptor protein 1/3

hsa04664 Fc epsilon RI signaling pathway - Homo sapiens (human) (5)



hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene

hsa04610 Complement and coagulation cascades - Homo sapiens (human) (5)



hsa:720 C4A, C4, C4A2, C4A3, C4A4, C4A6, C4S, CO4, CPAMD2, MGC164979, RG; complement component 4A (Rodgers blood group); K03989 complement component 4
hsa:727 C5, CPAMD4, FLJ17816, FLJ17822, MGC142298; complement component 5; K03994 complement component 5
hsa:730 C7; complement component 7; K03996 complement component 7
hsa:5327 PLAT, DKFZp686I03148, T-PA, TPA; plasminogen activator, tissue (EC:3.4.21.68); K01343 tissue plasminogen activator [EC:3.4.21.68]
hsa:5054 SERPINE1, PAI, PAI-1, PAI1, PLANH1; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1; K03982 plasminogen activator inhibitor-1

hsa05120 Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human) (5)



hsa:6352 CCL5, D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228; chemokine (C-C motif) ligand 5; K12499 C-C motif chemokine 5
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha

hsa05222 Small cell lung cancer - Homo sapiens (human) (5)



hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]

hsa05215 Prostate cancer - Homo sapiens (human) (5)



hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:2950 GSTP1, DFN7, FAEES3, GST3, GSTP, PI; glutathione S-transferase pi 1 (EC:2.5.1.18); K00799 glutathione S-transferase [EC:2.5.1.18]
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha

hsa05020 Prion diseases - Homo sapiens (human) (5)



hsa:727 C5, CPAMD4, FLJ17816, FLJ17822, MGC142298; complement component 5; K03994 complement component 5
hsa:730 C7; complement component 7; K03996 complement component 7
hsa:6352 CCL5, D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228; chemokine (C-C motif) ligand 5; K12499 C-C motif chemokine 5
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6

hsa05414 Dilated cardiomyopathy - Homo sapiens (human) (5)



hsa:27091 CACNG5, MGC126656, MGC126682; calcium channel, voltage-dependent, gamma subunit 5; K04870 voltage-dependent calcium channel gamma-5
hsa:1756 DMD, BMD, CMD3B, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272; dystrophin; K10366 dystrophin
hsa:6444 SGCD, 35DAG, CMD1L, DAGD, MGC22567, SG-delta, SGCDP, SGD; sarcoglycan, delta (35kDa dystrophin-associated glycoprotein); K12563 delta-sarcoglycan
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05212 Pancreatic cancer - Homo sapiens (human) (5)



hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:6774 STAT3, APRF, FLJ20882, HIES, MGC16063; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1

hsa05210 Colorectal cancer - Homo sapiens (human) (4)



hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:1630 DCC, CRC18, CRCR1, IGDCC1; deleted in colorectal carcinoma; K06765 deleted in colorectal carcinoma
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1

hsa04142 Lysosome - Homo sapiens (human) (4)



hsa:54 ACP5, MGC117378, TRAP; acid phosphatase 5, tartrate resistant (EC:3.1.3.2); K14379 tartrate-resistant acid phosphatase type 5 [EC:3.1.3.2]
hsa:1520 CTSS, FLJ50259, MGC3886; cathepsin S (EC:3.4.22.27); K01368 cathepsin S [EC:3.4.22.27]
hsa:6556 SLC11A1, LSH, NRAMP, NRAMP1; solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1; K12347 natural resistance-associated macrophage protein
hsa:285362 SUMF1, AAPA3037, FGE, MGC131853, MGC150436; sulfatase modifying factor 1 (EC:1.13.-.-); K13444 sulfatase modifying factor 1

hsa04970 Salivary secretion - Homo sapiens (human) (4)



hsa:486 FXYD2, ATP1G1, HOMG2, MGC12372; FXYD domain containing ion transport regulator 2; K01538 sodium/potassium-transporting ATPase subunit gamma (FXYD domain-containing ion transport regulator 2)
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:6263 RYR3; ryanodine receptor 3; K04963 ryanodine receptor 3

hsa04141 Protein processing in endoplasmic reticulum - Homo sapiens (human) (4)



hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:1410 CRYAB, CRYA2, CTPP2, HSPB5; crystallin, alpha B; K09542 crystallin, alpha B
hsa:5610 EIF2AK2, EIF2AK1, MGC126524, PKR, PRKR; eukaryotic translation initiation factor 2-alpha kinase 2 (EC:2.7.11.1); K08860 eukaryotic translation initiation factor 2-alpha kinase [EC:2.7.11.1]
hsa:10956 OS9, ERLEC2, OS-9; osteosarcoma amplified 9, endoplasmic reticulum lectin; K10088 protein OS-9

hsa04662 B cell receptor signaling pathway - Homo sapiens (human) (4)



hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene

hsa05220 Chronic myeloid leukemia - Homo sapiens (human) (4)



hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1

hsa04115 p53 signaling pathway - Homo sapiens (human) (4)



hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:5054 SERPINE1, PAI, PAI-1, PAI1, PLANH1; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1; K03982 plasminogen activator inhibitor-1

hsa04810 Regulation of actin cytoskeleton - Homo sapiens (human) (3)



hsa:929 CD14; CD14 molecule; K04391 CD14 antigen
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene

hsa04912 GnRH signaling pathway - Homo sapiens (human) (3)



hsa:4313 MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1; matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24); K01398 matrix metalloproteinase-2 (gelatinase A) [EC:3.4.24.24]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa04140 Regulation of autophagy - Homo sapiens (human) (3)



hsa:3451 IFNA17, IFN-alphaI, IFNA, INFA, LEIF2C1; interferon, alpha 17; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma

hsa04370 VEGF signaling pathway - Homo sapiens (human) (3)



hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:9047 SH2D2A, F2771, SCAP, TSAD, VRAP; SH2 domain containing 2A; K08273 SH2 domain protein 2A

hsa04310 Wnt signaling pathway - Homo sapiens (human) (3)



hsa:4041 LRP5, BMND1, EVR1, EVR4, HBM, LR3, LRP7, OPPG, OPS, OPTA1, VBCH2; low density lipoprotein receptor-related protein 5; K03068 low density lipoprotein receptor-related protein 5/6
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human) (3)



hsa:27091 CACNG5, MGC126656, MGC126682; calcium channel, voltage-dependent, gamma subunit 5; K04870 voltage-dependent calcium channel gamma-5
hsa:1756 DMD, BMD, CMD3B, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272; dystrophin; K10366 dystrophin
hsa:6444 SGCD, 35DAG, CMD1L, DAGD, MGC22567, SG-delta, SGCDP, SGD; sarcoglycan, delta (35kDa dystrophin-associated glycoprotein); K12563 delta-sarcoglycan

hsa04012 ErbB signaling pathway - Homo sapiens (human) (3)



hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
hsa:2065 ERBB3, ErbB-3, HER3, LCCS2, MDA-BF-1, MGC88033, c-erbB-3, c-erbB3, erbB3-S, p180-ErbB3, p45-sErbB3, p85-sErbB3; v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (EC:2.7.10.1); K05084 receptor tyrosine-protein kinase erbB-3 [EC:2.7.10.1]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa04350 TGF-beta signaling pathway - Homo sapiens (human) (3)



hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05012 Parkinson's disease - Homo sapiens (human) (3)



hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:4725 NDUFS5, CI-15k, CI15K; NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase); K03938 NADH dehydrogenase (ubiquinone) Fe-S protein 5 [EC:1.6.5.3 1.6.99.3]
hsa:374291 NDUFS7, CI-20, CI-20KD, FLJ45860, FLJ46880, MGC120002, MY017, PSST; NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3); K03940 NADH dehydrogenase (ubiquinone) Fe-S protein 7 [EC:1.6.5.3 1.6.99.3]

hsa05131 Shigellosis - Homo sapiens (human) (3)



hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha

hsa04360 Axon guidance - Homo sapiens (human) (3)



hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4
hsa:1630 DCC, CRC18, CRCR1, IGDCC1; deleted in colorectal carcinoma; K06765 deleted in colorectal carcinoma
hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]

hsa05219 Bladder cancer - Homo sapiens (human) (3)



hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:4313 MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1; matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24); K01398 matrix metalloproteinase-2 (gelatinase A) [EC:3.4.24.24]
hsa:4318 MMP9, CLG4B, GELB, MANDP2, MMP-9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35); K01403 matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35]

hsa04070 Phosphatidylinositol signaling system - Homo sapiens (human) (3)



hsa:3632 INPP5A, 5PTASE, DKFZp434A1721, MGC116947, MGC116949; inositol polyphosphate-5-phosphatase, 40kDa (EC:3.1.3.56); K01106 inositol-1,4,5-trisphosphate 5-phosphatase [EC:3.1.3.56]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa00480 Glutathione metabolism - Homo sapiens (human) (3)



hsa:2944 GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MGC26563, MU, MU-1; glutathione S-transferase mu 1 (EC:2.5.1.18); K00799 glutathione S-transferase [EC:2.5.1.18]
hsa:2947 GSTM3, GST5, GSTB, GSTM3-3, GTM3, MGC3310, MGC3704; glutathione S-transferase mu 3 (brain) (EC:2.5.1.18); K00799 glutathione S-transferase [EC:2.5.1.18]
hsa:2950 GSTP1, DFN7, FAEES3, GST3, GSTP, PI; glutathione S-transferase pi 1 (EC:2.5.1.18); K00799 glutathione S-transferase [EC:2.5.1.18]

hsa05100 Bacterial invasion of epithelial cells - Homo sapiens (human) (3)



hsa:857 CAV1, BSCL3, CGL3, MSTP085, VIP21; caveolin 1, caveolae protein, 22kDa; K06278 caveolin 1
hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]

hsa00982 Drug metabolism - cytochrome P450 - Homo sapiens (human) (3)



hsa:2944 GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MGC26563, MU, MU-1; glutathione S-transferase mu 1 (EC:2.5.1.18); K00799 glutathione S-transferase [EC:2.5.1.18]
hsa:2947 GSTM3, GST5, GSTB, GSTM3-3, GTM3, MGC3310, MGC3704; glutathione S-transferase mu 3 (brain) (EC:2.5.1.18); K00799 glutathione S-transferase [EC:2.5.1.18]
hsa:2950 GSTP1, DFN7, FAEES3, GST3, GSTP, PI; glutathione S-transferase pi 1 (EC:2.5.1.18); K00799 glutathione S-transferase [EC:2.5.1.18]

hsa04972 Pancreatic secretion - Homo sapiens (human) (3)



hsa:486 FXYD2, ATP1G1, HOMG2, MGC12372; FXYD domain containing ion transport regulator 2; K01538 sodium/potassium-transporting ATPase subunit gamma (FXYD domain-containing ion transport regulator 2)
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa04730 Long-term depression - Homo sapiens (human) (3)



hsa:1394 CRHR1, CRF-R, CRF1, CRFR1, CRH-R1h, CRHR, CRHR1L, CRHR1f; corticotropin releasing hormone receptor 1; K04578 corticotropin releasing hormone receptor 1
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa03050 Proteasome - Homo sapiens (human) (3)



hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:5696 PSMB8, D6S216, D6S216E, LMP7, MGC1491, PSMB5i, RING10; proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) (EC:3.4.25.1); K02740 20S proteasome subunit beta 8 [EC:3.4.25.1]
hsa:5698 PSMB9, LMP2, MGC70470, PSMB6i, RING12, beta1i; proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) (EC:3.4.25.1); K02741 20S proteasome subunit beta 9 [EC:3.4.25.1]

hsa04916 Melanogenesis - Homo sapiens (human) (3)



hsa:4157 MC1R, CMM5, MGC14337, MSH-R, SHEP2; melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor); K04199 melanocortin 1 receptor
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa00980 Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human) (3)



hsa:2944 GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MGC26563, MU, MU-1; glutathione S-transferase mu 1 (EC:2.5.1.18); K00799 glutathione S-transferase [EC:2.5.1.18]
hsa:2947 GSTM3, GST5, GSTB, GSTM3-3, GTM3, MGC3310, MGC3704; glutathione S-transferase mu 3 (brain) (EC:2.5.1.18); K00799 glutathione S-transferase [EC:2.5.1.18]
hsa:2950 GSTP1, DFN7, FAEES3, GST3, GSTP, PI; glutathione S-transferase pi 1 (EC:2.5.1.18); K00799 glutathione S-transferase [EC:2.5.1.18]

hsa04976 Bile secretion - Homo sapiens (human) (2)



hsa:486 FXYD2, ATP1G1, HOMG2, MGC12372; FXYD domain containing ion transport regulator 2; K01538 sodium/potassium-transporting ATPase subunit gamma (FXYD domain-containing ion transport regulator 2)
hsa:57835 SLC4A5, MGC129662, NBC4; solute carrier family 4, sodium bicarbonate cotransporter, member 5; K13857 solute carrier family 4 (sodium bicarbonate cotransporter), member 5

hsa00740 Riboflavin metabolism - Homo sapiens (human) (2)



hsa:54 ACP5, MGC117378, TRAP; acid phosphatase 5, tartrate resistant (EC:3.1.3.2); K14379 tartrate-resistant acid phosphatase type 5 [EC:3.1.3.2]
hsa:55312 RFK, FLJ11149, RIFK; riboflavin kinase (EC:2.7.1.26); K00861 riboflavin kinase [EC:2.7.1.26]

hsa05221 Acute myeloid leukemia - Homo sapiens (human) (2)



hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:6774 STAT3, APRF, FLJ20882, HIES, MGC16063; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3

hsa05130 Pathogenic Escherichia coli infection - Homo sapiens (human) (2)



hsa:929 CD14; CD14 molecule; K04391 CD14 antigen
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa04540 Gap junction - Homo sapiens (human) (2)



hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa05223 Non-small cell lung cancer - Homo sapiens (human) (2)

hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa04740 Olfactory transduction - Homo sapiens (human) (2)



hsa:401992 OR2T2, OR1-43, OR2T2P; olfactory receptor, family 2, subfamily T, member 2; K04257 olfactory receptor
hsa:403253 OR4A47, OR11-113; olfactory receptor, family 4, subfamily A, member 47; K04257 olfactory receptor

hsa00562 Inositol phosphate metabolism - Homo sapiens (human) (2)



hsa:3632 INPP5A, 5PTASE, DKFZp434A1721, MGC116947, MGC116949; inositol polyphosphate-5-phosphatase, 40kDa (EC:3.1.3.56); K01106 inositol-1,4,5-trisphosphate 5-phosphatase [EC:3.1.3.56]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]

hsa05211 Renal cell carcinoma - Homo sapiens (human) (2)



hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1

hsa00564 Glycerophospholipid metabolism - Homo sapiens (human) (2)



hsa:23171 GPD1L, GPD1-L, KIAA0089; glycerol-3-phosphate dehydrogenase 1-like (EC:1.1.1.8); K00006 glycerol-3-phosphate dehydrogenase (NAD+) [EC:1.1.1.8]
hsa:10162 LPCAT3, C3F, LPCAT, LPLAT_5, LPSAT, MBOAT5, OACT5, nessy; lysophosphatidylcholine acyltransferase 3 (EC:2.3.1.23); K13515 lysophospholipid acyltransferase 5 [EC:2.3.1.23 2.3.1.-]

hsa04330 Notch signaling pathway - Homo sapiens (human) (2)



hsa:182 JAG1, AGS, AHD, AWS, CD339, HJ1, JAGL1, MGC104644; jagged 1; K06052 jagged
hsa:4855 NOTCH4, FLJ16302, INT3, MGC74442, NOTCH3; notch 4; K02599 Notch

hsa04720 Long-term potentiation - Homo sapiens (human) (2)

hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa04960 Aldosterone-regulated sodium reabsorption - Homo sapiens (human) (2)

hsa:486 FXYD2, ATP1G1, HOMG2, MGC12372; FXYD domain containing ion transport regulator 2; K01538 sodium/potassium-transporting ATPase subunit gamma (FXYD domain-containing ion transport regulator 2)
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa04971 Gastric acid secretion - Homo sapiens (human) (2)

hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa00190 Oxidative phosphorylation - Homo sapiens (human) (2)

hsa:4725 NDUFS5, CI-15k, CI15K; NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase); K03938 NADH dehydrogenase (ubiquinone) Fe-S protein 5 [EC:1.6.5.3 1.6.99.3]
hsa:374291 NDUFS7, CI-20, CI-20KD, FLJ45860, FLJ46880, MGC120002, MY017, PSST; NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3); K03940 NADH dehydrogenase (ubiquinone) Fe-S protein 7 [EC:1.6.5.3 1.6.99.3]

hsa00350 Tyrosine metabolism - Homo sapiens (human) (2)

hsa:4282 MIF, GIF, GLIF, MMIF; macrophage migration inhibitory factor (glycosylation-inhibiting factor) (EC:5.3.3.12 5.3.2.1); K07253 phenylpyruvate tautomerase [EC:5.3.2.1]
hsa:5409 PNMT, MGC34570, PENT, PNMTase; phenylethanolamine N-methyltransferase (EC:2.1.1.28); K00553 phenylethanolamine N-methyltransferase [EC:2.1.1.28]

hsa04260 Cardiac muscle contraction - Homo sapiens (human) (2)

hsa:27091 CACNG5, MGC126656, MGC126682; calcium channel, voltage-dependent, gamma subunit 5; K04870 voltage-dependent calcium channel gamma-5
hsa:486 FXYD2, ATP1G1, HOMG2, MGC12372; FXYD domain containing ion transport regulator 2; K01538 sodium/potassium-transporting ATPase subunit gamma (FXYD domain-containing ion transport regulator 2)

hsa04270 Vascular smooth muscle contraction - Homo sapiens (human) (2)

hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa04614 Renin-angiotensin system - Homo sapiens (human) (1)

hsa:1636 ACE, ACE1, CD143, DCP, DCP1, MGC26566, MVCD3; angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1); K01283 peptidyl-dipeptidase A [EC:3.4.15.1]

hsa03008 Ribosome biogenesis in eukaryotes - Homo sapiens (human) (1)

hsa:134430 WDR36, DKFZp686I1650, GLC1G, TA-WDRP, TAWDRP, UTP21; WD repeat domain 36; K14554 U3 small nucleolar RNA-associated protein 21

hsa00670 One carbon pool by folate - Homo sapiens (human) (1)

hsa:4524 MTHFR; methylenetetrahydrofolate reductase (NAD(P)H) (EC:1.5.1.20); K00297 methylenetetrahydrofolate reductase (NADPH) [EC:1.5.1.20]

hsa05110 Vibrio cholerae infection - Homo sapiens (human) (1)

hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa00360 Phenylalanine metabolism - Homo sapiens (human) (1)

hsa:4282 MIF, GIF, GLIF, MMIF; macrophage migration inhibitory factor (glycosylation-inhibiting factor) (EC:5.3.3.12 5.3.2.1); K07253 phenylpyruvate tautomerase [EC:5.3.2.1]

hsa04964 Proximal tubule bicarbonate reclamation - Homo sapiens (human) (1)

hsa:486 FXYD2, ATP1G1, HOMG2, MGC12372; FXYD domain containing ion transport regulator 2; K01538 sodium/potassium-transporting ATPase subunit gamma (FXYD domain-containing ion transport regulator 2)

hsa03018 RNA degradation - Homo sapiens (human) (1)

hsa:694 BTG1; B-cell translocation gene 1, anti-proliferative; K14443 protein Tob/BTG

hsa04973 Carbohydrate digestion and absorption - Homo sapiens (human) (1)

hsa:486 FXYD2, ATP1G1, HOMG2, MGC12372; FXYD domain containing ion transport regulator 2; K01538 sodium/potassium-transporting ATPase subunit gamma (FXYD domain-containing ion transport regulator 2)

hsa00620 Pyruvate metabolism - Homo sapiens (human) (1)

hsa:2739 GLO1, GLOD1, GLYI; glyoxalase I (EC:4.4.1.5); K01759 lactoylglutathione lyase [EC:4.4.1.5]

hsa00534 Glycosaminoglycan biosynthesis - heparan sulfate - Homo sapiens (human) (1)

hsa:9953 HS3ST3B1, 30ST3B1, 3OST3B1; heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 (EC:2.8.2.30); K07809 [heparan sulfate]-glucosamine 3-sulfotransferase 3 [EC:2.8.2.30]

hsa00330 Arginine and proline metabolism - Homo sapiens (human) (1)

hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]

hsa04512 ECM-receptor interaction - Homo sapiens (human) (1)

hsa:5649 RELN, PRO1598, RL; reelin; K06249 reelin [EC:3.4.21.-]

hsa00030 Pentose phosphate pathway - Homo sapiens (human) (1)

hsa:9563 H6PD, DKFZp686A01246, G6PDH, GDH, MGC87643; hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) (EC:1.1.1.47 3.1.1.31); K13937 hexose-6-phosphate dehydrogenase [EC:1.1.1.47 3.1.1.31]

hsa04110 Cell cycle - Homo sapiens (human) (1)

hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1

hsa03010 Ribosome - Homo sapiens (human) (1)

hsa:6125 RPL5, DBA6, MGC117339; ribosomal protein L5; K02932 large subunit ribosomal protein L5e

hsa00510 N-Glycan biosynthesis - Homo sapiens (human) (1)



hsa:2530 FUT8, MGC26465; fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (EC:2.4.1.68); K00717 glycoprotein 6-alpha-L-fucosyltransferase [EC:2.4.1.68]

hsa:4245 MGAT1; mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (EC:2.4.1.101)

hsa05218 Melanoma - Homo sapiens (human) (1)

hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]

hsa05216 Thyroid cancer - Homo sapiens (human) (1)

hsa:5468 PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma; peroxisome proliferator-activated receptor gamma; K08530 peroxisome proliferator-activated receptor gamma

hsa03022 Basal transcription factors - Homo sapiens (human) (1)

hsa:2968 GTF2H4, TFB2, TFIIH; general transcription factor IIH, polypeptide 4, 52kDa; K03144 transcription initiation factor TFIIH subunit H4

hsa04974 Protein digestion and absorption - Homo sapiens (human) (1)

hsa:486 FXYD2, ATP1G1, HOMG2, MGC12372; FXYD domain containing ion transport regulator 2; K01538 sodium/potassium-transporting ATPase subunit gamma (FXYD domain-containing ion transport regulator 2)

hsa00230 Purine metabolism - Homo sapiens (human) (1)

hsa:5142 PDE4B, DKFZp686F2182, DPDE4, MGC126529, PDE4B5, PDEIVB; phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17); K01120 3',5'-cyclic-nucleotide phosphodiesterase [EC:3.1.4.17]

hsa04520 Adherens junction - Homo sapiens (human) (1)

hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]

hsa05213 Endometrial cancer - Homo sapiens (human) (1)

hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]

hsa00512 Mucin type O-Glycan biosynthesis - Homo sapiens (human) (1)

hsa:56913 C1GALT1, C1GALT, T-synthase; core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 (EC:2.4.1.122); K00731 glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase [EC:2.4.1.122]

hsa03420 Nucleotide excision repair - Homo sapiens (human) (1)

hsa:2968 GTF2H4, TFB2, TFIIH; general transcription factor IIH, polypeptide 4, 52kDa; K03144 transcription initiation factor TFIIH subunit H4

hsa04120 Ubiquitin mediated proteolysis - Homo sapiens (human) (1)

hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]

hsa04530 Tight junction - Homo sapiens (human) (1)

hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa05214 Glioma - Homo sapiens (human) (1)

hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa04910 Insulin signaling pathway - Homo sapiens (human) (1)

hsa:868 CBLB, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, FLJ36865, FLJ41152, RNF56; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]

hsa04742 Taste transduction - Homo sapiens (human) (1)

hsa:40 ACCN1, ACCN, ASIC2, ASIC2a, BNC1, BNaC1, MDEG, hBNaC1; amiloride-sensitive cation channel 1, neuronal; K04828 amiloride-sensitive cation channel 1, neuronal (degenerin)

hsa04146 Peroxisome - Homo sapiens (human) (1)

hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]

hsa00601 Glycosphingolipid biosynthesis - lacto and neolacto series - Homo sapiens (human) (1)

hsa:10317 B3GALT5, B3GalT-V, B3GalTx, B3T5, GLCT5, beta3Gal-T5; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5; K03877 beta-1,3-galactosyltransferase 5 [EC:2.4.1.-]

hsa00533 Glycosaminoglycan biosynthesis - keratan sulfate - Homo sapiens (human) (1)

hsa:2530 FUT8, MGC26465; fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (EC:2.4.1.68); K00717 glycoprotein 6-alpha-L-fucosyltransferase [EC:2.4.1.68]

hsa02010 ABC transporters - Homo sapiens (human) (1)

hsa:6891 TAP2, ABC18, ABCB3, APT2, D6S217E, PSF2, RING11; transporter 2, ATP-binding cassette, sub-family B (MDR/TAP); K05654 ATP-binding cassette, subfamily B (MDR/TAP), member 3

hsa00603 Glycosphingolipid biosynthesis - globo series - Homo sapiens (human) (1)

hsa:10317 B3GALT5, B3GalT-V, B3GalTx, B3T5, GLCT5, beta3Gal-T5; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5; K03877 beta-1,3-galactosyltransferase 5 [EC:2.4.1.-]

hsa03320 PPAR signaling pathway - Homo sapiens (human) (1)

hsa:5468 PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma; peroxisome proliferator-activated receptor gamma; K08530 peroxisome proliferator-activated receptor gamma

hsa00565 Ether lipid metabolism - Homo sapiens (human) (1)

hsa:7941 PLA2G7, LDL-PLA2, LP-PLA2, PAFAH; phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (EC:3.1.1.47); K01062 1-alkyl-2-acetylglycerophosphocholine esterase [EC:3.1.1.47]

hsa04930 Type II diabetes mellitus - Homo sapiens (human) (1)

hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa00140 Steroid hormone biosynthesis - Homo sapiens (human) (1)

hsa:1589 CYP21A2, CA21H, CAH1, CPS1, CYP21, CYP21B, MGC150536, MGC150537, P450c21B; cytochrome P450, family 21, subfamily A, polypeptide 2 (EC:1.14.99.10); K00513 cytochrome P450, family 21, subfamily A (steroid 21-monooxygenase) [EC:1.14.99.10]

hsa04320 Dorso-ventral axis formation - Homo sapiens (human) (1)

hsa:4855 NOTCH4, FLJ16302, INT3, MGC74442, NOTCH3; notch 4; K02599 Notch

hsa00100 Steroid biosynthesis - Homo sapiens (human) (1)

hsa:1594 CYP27B1, CP2B, CYP1, CYP1alpha, CYP27B, P450c1, PDDR, VDD1, VDDR, VDDRI, VDR; cytochrome P450, family 27, subfamily B, polypeptide 1 (EC:1.14.13.13); K07438 cytochrome P450, family 27, subfamily B (25-hydroxyvitamin D3 1alpha-hydroxylase) [EC:1.14.13.13]